August 20, 2017

August 18, 2017

Subscribe to Latest Legal News and Analysis

ITC Publishes Determinations On Biodiesel Antidumping, Countervailing Investigation

On May 12, 2017, the U.S. International Trade Commission (ITC) published in the Federal Register its preliminary determinations regarding the antidumping (AD) and countervailing duty (CVD) investigations of biodiesel imports from Argentina and Indonesia.  ITC confirmed that there is a reasonable indication that an industry in the U.S. is materially injured by imports of biodiesel from Argentina and Indonesia, which are alleged to be sold in the U.S. at less than fair value (LTFV) and to be subsidized by the governments of Argentina and Indonesia.  As a result, the U.S. Department of Commerce (DOC) will continue conducting its AD and CVD investigation.  According to the notice, ITC will publish a final phase notice of scheduling in the Federal Register upon notice from DOC of affirmative preliminary determinations in the investigations, or, if the preliminary determinations are negative, upon notice of affirmative final determinations in those investigations.  More information on the ITC determinations, which were made pursuant to Section 703(a) and 733(a) of the Tariff Act of 1930, is currently available on ITC’s website and will be available in the ITC public report titled “Biodiesel from Argentina and Indonesia: Investigation” (publication number 4690).

©2017 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lauren Graham, Bergeson Campbell Law Firm, Consortia Manager
Ph D

Lauren M. Graham, Ph.D., Manager with B&C® Consortia Management (BCCM), guides and facilitates effective consortia performance in advocacy programs, public outreach, product stewardship, and testing and compliance.  Dr. Graham offers BCCM consortia clients the scientific acumen she gained in academia and industry, and the organizational, editorial, and promotional skills honed while with the Royal Society of Chemistry (RSC), to assist consortia in reaching and exceeding their institutional goals.

Dr. Graham...

484-894-0976